Advances in experimental animal models of hepatocellular carcinoma

被引:6
|
作者
Li, Jing [1 ]
Wang, Xin [1 ]
Ren, Mudan [1 ]
He, Shuixiang [1 ]
Zhao, Yan [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, Xian 710061, Shaanxi, Peoples R China
来源
CANCER MEDICINE | 2023年 / 12卷 / 14期
关键词
animal model; hepatocellular carcinoma; transgenic; MOUSE MODELS; LIVER-CANCER; EXPRESSION PATTERNS; OXIDATIVE STRESS; CATENIN PATHWAY; BETA-CATENIN; GENE-THERAPY; HBX GENE; C-MYC; MICE;
D O I
10.1002/cam4.6163
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with insidious early symptoms, easy metastasis, postoperative recurrence, poor drug efficacy, and a high drug resistance rate when surgery is missed, leading to a low 5-year survival rate. Research on the pathogenesis and drugs is particularly important for clinical treatment. Animal models are crucial for basic research, which is conducive to studying pathogenesis and drug screening more conveniently and effectively. An appropriate animal model can better reflect disease occurrence and development, and the process of anti-tumor immune response in the human body. This review summarizes the classification, characteristics, and advances in experimental animal models of HCC to provide a reference for researchers on model selection.
引用
收藏
页码:15261 / 15276
页数:16
相关论文
共 50 条
  • [1] Animal models for hepatocellular carcinoma
    Zhang, Hui Emma
    Henderson, James M.
    Gorrell, Mark D.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (05): : 993 - 1002
  • [2] Animal Models of Hepatocellular Carcinoma Prevention
    Shankaraiah, Ram C.
    Gramantieri, Laura
    Fornari, Francesca
    Sabbioni, Silvia
    Callegari, Elisa
    Negrini, Massimo
    CANCERS, 2019, 11 (11)
  • [3] Experimental models of hepatocellular carcinoma
    Newell, Philippa
    Villanueva, Augusto
    Friedman, Scott. L.
    Koike, Kazuhiko
    Llovet, Josep M.
    JOURNAL OF HEPATOLOGY, 2008, 48 (05) : 858 - 879
  • [4] Advances in hepatocellular carcinoma drug resistance models
    Xiang, Yien
    Wu, Jun
    Qin, Hanjiao
    FRONTIERS IN MEDICINE, 2024, 11
  • [5] Hepatocellular carcinoma: insight from animal models
    Li, Yan
    Tang, Zhao-You
    Hou, Jin-Xuan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (01) : 32 - 43
  • [6] Establishment of Animal Models with Orthotopic Hepatocellular Carcinoma
    Lee T.K.
    Na K.S.
    Kim J.
    Jeong H.-J.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (3) : 173 - 179
  • [7] Hepatocellular carcinoma: insight from animal models
    Yan Li
    Zhao-You Tang
    Jin-Xuan Hou
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 32 - 43
  • [8] The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma
    Ning Zhang
    Lu Wang
    Ying Liang
    Yi-Ming Zhao
    Qiong Xue
    Wei-Zhong Wu
    Hui-Chuan Sun
    Jia Fan
    Zhao-You Tang
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1447 - 1453
  • [9] Stem Cell Origins and Animal Models of Hepatocellular Carcinoma
    Aravalli, Rajagopal N.
    Steer, Clifford J.
    Sahin, M. Behnan
    Cressman, Erik N. K.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (05) : 1241 - 1250
  • [10] The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma
    Zhang, Ning
    Wang, Lu
    Liang, Ying
    Zhao, Yi-Ming
    Xue, Qiong
    Wu, Wei-Zhong
    Sun, Hui-Chuan
    Fan, Jia
    Tang, Zhao-You
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1447 - 1453